Gilder Gagnon Howe & CO LLC Evolus, Inc. Transaction History
Gilder Gagnon Howe & CO LLC
- $8.56 Billion
- Q4 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 702,239 shares of EOLS stock, worth $9.82 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
702,239
Previous 181,380
287.16%
Holding current value
$9.82 Million
Previous $2.94 Million
163.85%
% of portfolio
0.09%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$72 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$69.9 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$56.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$44.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$43.8 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $785M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...